STING agonist-9
Product Specifications
UNSPSC Description
STING agonist-9 (Compound 45) is a potent STING agonist with an EC50 of 1.2 nM and 32.82 μM against h-STING and m-STING, respectively. STING agonist-9 shows antitumor activity[1].
Target Antigen
STING
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sting-agonist-9.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(OCCCN2CCOCC2)=C3C(N=C(NC(C4=CC(C)=NN4CC)=O)N3C/C=C/CN5C(NC(C6=CC(C)=NN6CC)=O)=NC7=C5SC(C(N)=O)=C7)=C1)N
Molecular Weight
825.94
References & Citations
[1]Niu J, et al. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration. Eur J Med Chem. 2022 Aug 5;238:114482.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147834/STING-agonist-9-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147834/
Clinical Information
No Development Reported
CAS Number
2653337-73-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
